MENU
+Compare
PRE
Stock ticker: NASDAQ
AS OF
Jul 16, 04:30 PM (EDT)
Price
$8.38
Change
+$0.13 (+1.58%)
Capitalization
51.51M

PRE Prenetics Global Limited Forecast, Technical & Fundamental Analysis

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health... Show more

PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRE with price predictions
Jul 15, 2025

PRE in +4.56% Uptrend, advancing for three consecutive days on July 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PRE advanced for three days, in of 144 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where PRE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRE as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.229) is normal, around the industry mean (24.469). P/E Ratio (0.970) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.147) is also within normal values, averaging (42.883).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRE is expected to report earnings to fall 96.09% to -5 cents per share on March 12

Prenetics Global Limited PRE Stock Earnings Reports
Q4'23
Est.
$-0.05
Q4'24
Missed
by $1.58
Q3'23
Beat
by $0.37
Q2'23
Missed
by $0.70
Q1'23
Missed
by $0.01
The last earnings report on April 30 showed earnings per share of -127 cents, missing the estimate of 30 cents. With 27.59K shares outstanding, the current market capitalization sits at 51.51M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Unit 701-706, K11 Atelier King’s Road
Phone
+852 22109588
Employees
400
Web
https://www.prenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLYX2.530.04
+1.61%
flyExclusive
YGRAF0.760.01
+0.86%
Yangarra Resources Ltd.
FSPKF22.10N/A
N/A
Fisher & Paykel Healthcare Corp. Ltd.
CADLF5.50N/A
N/A
CADELER AS
GOSS1.45-0.08
-5.23%
Gossamer Bio

PRE and Stocks

Correlation & Price change

A.I.dvisor tells us that PRE and DSRLF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRE and DSRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRE
1D Price
Change %
PRE100%
+2.48%
DSRLF - PRE
25%
Poorly correlated
N/A
NUWE - PRE
24%
Poorly correlated
-11.72%
SHC - PRE
23%
Poorly correlated
-1.98%
PDEX - PRE
23%
Poorly correlated
-2.27%
IDXX - PRE
23%
Poorly correlated
-0.90%
More